Clinical Trials
at Scott & White
Clinical trials are studies, managed by government agencies, educational institutions, private not-for-profit organizations, or commercial businesses, to develop, produce, and evaluate the effectiveness of new treatments and therapies for diseases.
Learn more about clinical trials »
- Cancer-Specific Clinical Trials
- All Cancer Treatments and Therapies
Listing of all cancer clinical trials and protocols for various disease sites. Some trials are sponsored by Scott & White while some are sponsored by outside agencies.
Protox Phase IIa Trial (Prostate Cancer Treatment)
The purpose of this study is to determine the safety and tolerance of different injection schemes of PRX302, given by local injection (shot) into the prostate in men with localized recurrence of prostate cancer.
Phase I Clinical Trials
Phase I trials are the first studies to evaluate how a new therapy should be administered - how often, and in what dosage. The focus is to determine safety (drug dose, device safety, or other therapy's safety) for the next phase of testing.
T-Cell Phase I/II
AML/MDS/myeloproliferative CD33
Refractory/Relapsed or Elderly/Poor-risk AML
Refractory/Relapsed Hodgkin's Lymphoma
- All Other Clinical Trials
- Parkinson, Cardiology, Ob/Gyn, etc.
Clinical trials through Research and Education are found in various medical areas that are easily broken down into specific categories.
All [Non-Cancer] Clinical Trials
Select by category:
- Anesthesia
- Bone, Joint and Muscle
- Brain and Nervous System
- Digestive system (stomach, intestines)
- Eye
- Heart, Blood, Vessels
- Kidney, Liver
- Lungs
- Mental Health
- Obstetrics/Gynecology
- Pediatrics
- Surgery
- Urology (prostate, bladder, urinary tract, urethra)
Research & Education
Health Care Professionals
Patients